Jason Pitofsky insider trades

Open-market stock purchases and sales by Jason Pitofsky, SVP Controller at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 4, 2024.

Recent trades

DateStockTradeValue
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$15.5K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$405K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$304K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$20.3K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$438K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$160K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$58.5K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$29K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$113K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$785
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncSold$41.6K
Feb 9, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Dec 8, 2025REGN Regeneron Pharmaceuticals, IncSold (not open market)$705K
Dec 5, 2025REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Dec 5, 2025REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Nov 7, 2025REGN Regeneron Pharmaceuticals, IncSold$281K

Companies traded

  • REGN Regeneron Pharmaceuticals, Inc: 13 sales, last Feb 9, 2026

Get free alerts when Jason Pitofsky files a new trade →